{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:20:53Z","timestamp":1789852853744,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.semarthrit.2011.08.006","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T04:49:39Z","timestamp":1320814179000},"page":"712-719","source":"Crossref","is-referenced-by-count":79,"title":["Biologics in Relapsing Polychondritis: A Literature Review"],"prefix":"10.1016","volume":"41","author":[{"given":"Fernando","family":"Kemta Lekpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2011.08.006_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.autrev.2010.02.016","article-title":"Relapsing polychondritis: An autoimmune disease with many faces","volume":"9","author":"Lahmer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/sarh.2002.32586","article-title":"Relapsing polychondritis: a clinical review","volume":"31","author":"Letko","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib3","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/art.11281","article-title":"Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis","volume":"48","author":"Kraus","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib4","first-page":"553","article-title":"Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis","volume":"28","author":"Kemta Lekpa","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib5","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/art.20613","article-title":"Serum cytokine profiles in relapsing polychondritis suggest monocyte\/macrophage activation","volume":"50","author":"Stabler","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib6","first-page":"96","article-title":"Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients","volume":"24","author":"Zeuner","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib7","first-page":"1419","article-title":"Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis","volume":"20","author":"Alsalameh","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1529-0131(200004)43:4<939::AID-ANR28>3.0.CO;2-Z","article-title":"Autoreactivity against matrilin-1 in a patient with relapsing polychondritis","volume":"43","author":"Buckner","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9440(10)63183-5","article-title":"Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease","volume":"164","author":"Hansson","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(66)90023-4","article-title":"Relapsing polychondritis","volume":"41","author":"Dolan","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJM197811302992202","article-title":"Antibodies to type II collagen in relapsing polychondritis","volume":"299","author":"Foidart","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00371591","article-title":"Autoantibodies to cartilage collagens in relapsing polychondritis","volume":"285","author":"Yang","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/rheumatology\/keg280","article-title":"Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab","volume":"42","author":"Mpofu","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib14","first-page":"1394","article-title":"Sustained response to infliximab in 2 patients with refractory relapsing polychondritis","volume":"30","author":"Saadoun","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/01.prs.0000278184.60488.8e","article-title":"Durability of nasal reconstruction in an adolescent with relapsing polychondritis treated with infliximab","volume":"120","author":"Bell","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/rheumatology\/kep224","article-title":"Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1468-3083.2008.02923.x","article-title":"Successful treatment of recalcitrant relapsing polychondritis with monoclonal antibodies","volume":"23","author":"Ratzinger","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib18","first-page":"629","article-title":"Successful treatment of relapsing polychondritis with infliximab","volume":"22","author":"Richez","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib19","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jaad.2008.05.010","article-title":"Takayasu disease presenting as malignant pyoderma gangrenosum in a child with relapsing polychondritis","volume":"59","author":"Ghosn","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib20","first-page":"211","article-title":"Infliximab in relapsing polychondritis","volume":"50","author":"de Barros","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.eye.6701457","article-title":"The successful use of infliximab in resistant relapsing polychondritis and associated scleritis","volume":"19","author":"Cazabon","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09273941003624914","article-title":"Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis","volume":"18","author":"Jabbarvand","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.62.1.81","article-title":"Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab","volume":"62","author":"Matzkies","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10067-007-0688-9","article-title":"Magic syndrome and true aortic aneurysm","volume":"27","author":"Hidalgo-Tenorio","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib25","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/rheumatology\/kep172","article-title":"Aortic aneurysm in MAGIC syndrome successfully managed with combined anti-TNF-alpha and stent grafting","volume":"48","author":"Mekinian","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/RHU.0b013e3181dfce16","article-title":"A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab","volume":"16","author":"Geissal","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib27","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/kem229","article-title":"Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis","volume":"46","author":"Seymour","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/kel041","article-title":"Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)","volume":"45","author":"Vounotrypidis","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jbspin.2008.02.011","article-title":"Efficacy of anakinra in a patient with refractory relapsing polychondritis","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00296-009-0981-9","article-title":"Relapsing polychondritis: new therapeutic strategies with biological agents","volume":"30","author":"Buonuomo","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib31","first-page":"139","article-title":"Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center","volume":"32","author":"de Oliveira","year":"2007","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/03009740701747160","article-title":"Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia","volume":"37","author":"Subrahmanyam","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.24366","article-title":"Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients","volume":"61","author":"Leroux","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00296-009-1308-6","article-title":"Treatment of relapsing polychondritis in the era of biological agents","volume":"30","author":"McCarthy","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/rheumatology\/ken468","article-title":"Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis","volume":"48","author":"Kawai","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/rheumatology\/kep436","article-title":"Abatacept for relapsing polychondritis","volume":"49","author":"Moulis","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib37","first-page":"1413","article-title":"Treatment of relapsing polychondritis with a TNF antagonist","volume":"32","author":"Carter","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib38","first-page":"128","article-title":"The development of trigeminal neuralgia related to auricular chondritis in a patient with rheumatoid arthritis-relapsing polychondritis and its treatment with etanercept","volume":"27","author":"Pamuk","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00393-009-0601-9","article-title":"Successful therapy with etanercept in relapsing polychondritis","volume":"69","author":"Schr\u00e4der","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10067-010-1488-1","article-title":"Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab","volume":"29","author":"Lahmer","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.006_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.lpm.2009.01.012","article-title":"Indications of anakinra","volume":"38","author":"Chauffier","year":"2009","journal-title":"Presse Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T13:56:02Z","timestamp":1543413362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017211002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0049017211002253"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.006","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}